Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 117 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1161 10.1 months Malignant pleural mesothelioma 4 Chemotherapy
JuntendoUniversitySchoolofMedicine Japan 3/2014
Treatment Details: Patients: This study involved malignant pleural mesothelioma patients who were divided into two separate treatment groups. Group A consisted of 17 patients with a median age of 66 years; 9
 
1162 10.1 months Primary central nervous system lymphoma 5 Chemotherapy
Northwestern University, Feinberg School of Medicine United States 8/2012
Treatment Details: Patients: This study involved 11 primary central nervous system lymphoma patients who had received prior chemotherapy. The median patient age was 69.8 years and 8 were male. Treatment:
 
1163 10.1 months Advanced non-squamous NSCLC 5 Biologic therapy
Chemotherapy
Poznan University of Medical Sciences Poland 10/2012
Treatment Details: Patients: This phase 3 study involved platinum-pretreated patients with advanced or metastatic non-squamous non-small-cell lung cancer patients who were divided into two separate treatment
 
1164 10.1 months Melanoma 4 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 5/2008
Treatment Details: Patients: This phase 2 study involved 50 melanoma patients who had no prior chemotherapy, 31 of whom were males. The patient age range was 15 to 92 years. Treatment: Patients were trea
 
1165 10.1 months Non-small-cell lung cancer 4 Chemotherapy
National Cancer Center Hospital Japan 3/2003
Treatment Details: Patients: This Phase I/II trial involved 56 patients with a median age of 56 years. Forty-five patients had non-small-cell lung cancer (majority with adenocarcinoma) and eleven patients had
 
1166 10.1 months Malignant pleural mesothelioma 4 Chemotherapy
Institut Gustave Roussy France 1/2003
Treatment Details: Patients: This Phase II study involved 70 patients with malignant pleural mesothelioma; 51 men and 19 women. Fifty-five patients had not received prior chemotherapy. Treatment: The treat
 
1167 10.1 months Hormone-refractory prostate cancer 4 Chemotherapy
Rudolfstiftung Austria 1/2004
Treatment Details: Patients: This Phase II study involved a total of 90 patients with hormone refractory prostate cancer. Patients were divided into two groups of 45 patients each: Group 1 and Group 2. T
 
1168 10.1 months Malignant pleural mesothelioma 4 Chemotherapy
Dana Farber Cancer Institute United States 3/2008
Treatment Details: Patients: This phase II study involved 108 patients with malignant pleural mesothelioma. The majority were men and had not received prior radiation therapy. These patients ranged in age f
 
1169 10.1 months advanced colorectal cancer 4 Chemotherapy
University of Pittsburgh School of Medicine United States 3/2006
Treatment Details: Patients: This Phase II study involved 14 patients (11 men, 3 women, median age 70) with advanced colorectal cancer. All patients had received surgery or chemotherapy before the study. T
 
1170 10.1 months Metastatic melanoma 5 Biologic therapy
Dana–Farber Cancer Institute United States 8/2010
Treatment Details: Patients: This study involved metastatic melanoma patients that were positive for HLA-A*0201, which is a specific version of a gene involved in the immune response. Patients were divided i
 
Page 117 of 187  | Previous Page  | Next Page